Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human MBL Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB23071SP
This item is not returnable.
View return policy
Description
MBL Monoclonal specifically detects MBL in Human samples. It is validated for Blockade of Receptor-ligand Interaction.Specifications
MBL | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
COLEC1, COLEC1collectin-1, Collectin-1, HSMBPC, Mannan-binding protein, Mannose-binding lectin, mannose-binding lectin (protein C) 2, soluble, mannose-binding lectin (protein C) 2, soluble (opsonic defect), mannose-binding protein C, MBL2, MBL2D, MBLmannan-binding lectin, MBP, MBP1, MBP1mannose-binding lectin 2, soluble (opsonic defect), MBP-C, MGC116832, MGC116833 | |
Mouse | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
4153 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2a |
Blockade of Receptor-ligand Interaction | |
285623 | |
Blockade of Receptor-ligand Interaction | |
AAH96182 | |
MBL2 | |
Mouse myeloma cell line NS0-derived recombinant human MBL Glu21-Ile248 Accession # AAH96182 | |
25 μg | |
Primary | |
Detects human MBL in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant mouse MBL-2 is observed. | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction